Skip to main content
. 2012 Jan 17;10(1-4):257–260. doi: 10.1159/000334285

Table 2.

Non-PARK loci/genes

Disease/syndrome Gene Locus Inheritance
SCA2 SCA 2 12q24.12 AD
SCA3 SCA 3 14q32.12 AD
SCA12 PPP2R2B 5q32 AD
SCA17 TBP 6q27 AD
SCA21 7p21.3-p15.1 AD
DYT5/DYT14 GCH1 14q22.2 AD
DYT12 ATP1A3 19q13.2 AD
FTDP-17T MAPT 17q21.31 AD
FTDP-17U PGRN 17q21.31 AD
FTD-3 CHMP2B 3p11.2 AD
FTD FUS 16p11.2 AD
9p-linked FTD/ALS C9ORF72 9p21.2 AD
Perry syndrome DCTN1 2p13.1 AD
Neuroferritinopathy FTL 19q13.33 AD
Huntington disease HTT 4p16.3 AD
DYT5 TH 11p15.5 AR
DYT16 PRKRA 2q31.2 AR
SPG11 Spatacsin 15q21.1 AR
Wilson's disease ATP7B 13q14.3 AR
Niemann-Pick disease NPC1 18q11.2 AR
PKAN PANK2 20p13 AR
DYT3 TAF1, TAF1/DYT3 Xq13.1 X-linked
Fragile X tremor ataxia syndrome FMR1 Xq27.3 X-linked
Complex 1 ND4 mitochondrial

SCA = Spinocerebellar ataxia; DYT = dystonia; FTDP-17T = frontotemporal dementia with parkinsonism linked to chromosome 17 with tau pathology; FTDP-17U = frontotemporal dementia with parkinsonism linked to chromosome 17 with ubiquitin pathology; FTD-3 = frontotemporal dementia linked to chromosome 3; FTD = frontotemporal dementia; 9p-linked FTD/ALS = chromosome 9p-linked frontotemporal dementia/amyotrophic lateral sclerosis; SPG = spastic paraplegia; PKAN = pantothenate kinase-associated neurodegeneration; PPP2R2B = protein phosphatase 2, regulatory subunit B, β; TBP = TATA box-binding protein; MAPT = microtubule-associated protein tau; PGRN = progranulin; CHMP2B = chromatin modifying protein 2B; FUS = fused in sarcoma; DCTN1 = dynactin 1; FTL = ferritin light chain; HTT = huntingtin; TH = tyrosine hydroxylase; PRKRA = protein kinase, interferon-inducible double-stranded RNA-dependent activator; ATP7B = ATPase, Cu2+ transporting, β-polypeptide; NPC1 = Niemann-Pick disease type C1; PANK2 = pantothenate kinase 2; TAF1 = TATA box-binding protein-associated factor 1; FMR1 = fragile X mental retardation 1; ND4 = NADH dehydrogenase, subunit 4; AD = autosomal dominant; AR = autosomal recessive.